Global Cancer Supportive Care Medicine Market Research Report 2012-2023

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 Antiemetic Drugs

1.2.1.2 Erythropoietin-Stimulating Agents

1.2.1.3 Granulocyte-Stimulating Agents

1.2.1.4 Analgesics

1.2.1.5 Others

1.2.2 by Application

1.2.2.1 Chemotherapy-Induced Anemia

1.2.2.2 CINV

1.2.2.3 Bone Metastasis

1.2.2.4 Cancer Pain

1.2.2.5 Others

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Antiemetic Drugs Market, 2012-2017

4.1.2 Erythropoietin-Stimulating Agents Market, 2012-2017

4.1.3 Granulocyte-Stimulating Agents Market, 2012-2017

4.1.4 Analgesics Market, 2012-2017

4.1.5 Others Market, 2012-2017

4.2 Market Forecast

4.2.1 Antiemetic Drugs Market Forecast, 2018-2023

4.2.2 Erythropoietin-Stimulating Agents Market Forecast, 2018-2023

4.2.3 Granulocyte-Stimulating Agents Market Forecast, 2018-2023

4.2.4 Analgesics Market Forecast, 2018-2023

4.2.5 Others Market Forecast, 2018-2023

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Chemotherapy-Induced Anemia Market, 2012-2017

5.1.2 CINV Market, 2012-2017

5.1.3 Bone Metastasis Market, 2012-2017

5.1.4 Cancer Pain Market, 2012-2017

5.1.5 Others Market, 2012-2017

5.2 Market Forecast

5.2.1 Chemotherapy-Induced Anemia Market Forecast, 2018-2023

5.2.2 CINV Market Forecast, 2018-2023

5.2.3 Bone Metastasis Market Forecast, 2018-2023

5.2.4 Cancer Pain Market Forecast, 2018-2023

5.2.5 Others Market Forecast, 2018-2023

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2012-2017

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2012-2017

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2012-2017

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2012-2017

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2012-2017

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2018-2023

6.2.2 North America Market Forecast, 2018-2023

6.2.3 Europe Market Forecast, 2018-2023

6.2.4 South America Market Forecast, 2018-2023

6.2.5 Middle East & Africa Market Forecast, 2018-2023

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Amgen

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 Helsinn Healthcare

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 Johnson &Johnson

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 Merck

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 F. Hoffmann-La Roche

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 GlaxoSmithKline

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Heron Therapeutics

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 Kyowa Hakko Kirin

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.9 Novartis

8.9.1 Profile

8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.10 TESARO

8.10.1 Profile

8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.11 Teva Pharmaceutical Industries

9 Conclusion

Table Products Segment of Cancer Supportive Care Medicine

Table Antiemetic Drugs Overview

Table Erythropoietin-Stimulating Agents Overview

Table Granulocyte-Stimulating Agents Overview

Table Analgesics Overview

Table Others Overview

Table Global Cancer Supportive Care Medicine Market by Type, 2011-2022 (USD Million)

Table Application Segment of Cancer Supportive Care Medicine

Table Chemotherapy-Induced Anemia Overview

Table CINV Overview

Table Bone Metastasis Overview

Table Cancer Pain Overview

Table Others Overview

Table Global Cancer Supportive Care Medicine Market by Application, 2011-2022 (USD Million)

Table Global Cancer Supportive Care Medicine Market by Region, 2011-2022 (USD Million)

Table Cost of Cancer Supportive Care Medicine

Table Market Dynamics

Table Policy of Cancer Supportive Care Medicine

Table GDP of Major Countries

Table Antiemetic Drugs CAGR by Revenue and Volume, 2012-2017

Table Erythropoietin-Stimulating Agents CAGR by Revenue and Volume, 2012-2017

Table Granulocyte-Stimulating Agents CAGR by Revenue and Volume, 2012-2017

Table Analgesics CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017

Table Antiemetic Drugs CAGR by Revenue and Volume, 2012-2022

Table Erythropoietin-Stimulating Agents CAGR by Revenue and Volume, 2012-2022

Table Granulocyte-Stimulating Agents CAGR by Revenue and Volume, 2012-2022

Table Analgesics CAGR by Revenue and Volume, 2012-2022

Table Others CAGR by Revenue and Volume, 2012-2022

Table Chemotherapy-Induced Anemia CAGR by Revenue and Volume, 2012-2017

Table CINV CAGR by Revenue and Volume, 2012-2017

Table Bone Metastasis CAGR by Revenue and Volume, 2012-2017

Table Cancer Pain CAGR by Revenue and Volume, 2012-2017

Table Others CAGR by Revenue and Volume, 2012-2017